| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 49835* | 2014 |
| Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines DA Garcia, TP Baglin, JI Weitz, MM Samama Chest 141 (2), e24S-e43S, 2012 | 1270 | 2012 |
| Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study T Baglin, R Luddington, K Brown, C Baglin The Lancet 362 (9383), 523-526, 2003 | 907 | 2003 |
| Guidelines on oral anticoagulation with warfarin D Keeling, T Baglin, C Tait, H Watson, D Perry, C Baglin, S Kitchen, ... Br J Haematol 154 (3), 311-24, 2011 | 817 | 2011 |
| Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation PW Collins, S Hirsch, TP Baglin, G Dolan, J Hanley, M Makris, ... Blood 109 (5), 1870-1877, 2007 | 807 | 2007 |
| International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, P Debourdeau, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 56-70, 2013 | 697 | 2013 |
| Clinical guidelines for testing for heritable thrombophilia. T Baglin, E Gray, M Greaves, BJ Hunt, D Keeling, S Machin, I Mackie, ... British journal of haematology 149 (2), 2010 | 664 | 2010 |
| Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of … AM Veitch, G Vanbiervliet, AH Gershlick, C Boustiere, TP Baglin, LA Smith, ... Endoscopy 48 (04), 385-402, 2016 | 606 | 2016 |
| Guidelines on oral anticoagulation (warfarin): –2005 update. TP Baglin, DM Keeling, HG Watson British journal of haematology 132 (3), 2006 | 563 | 2006 |
| Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment J Taube, D Halsall, T Baglin Blood, The Journal of the American Society of Hematology 96 (5), 1816-1819, 2000 | 560 | 2000 |
| Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ... Thrombosis and haemostasis 86 (09), 809-816, 2001 | 548 | 2001 |
| Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines JW Eikelboom, J Hirsh, FA Spencer, TP Baglin, JI Weitz Chest 141 (2), e89S-e119S, 2012 | 537 | 2012 |
| Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH) A Tosetto, A Iorio, M Marcucci, T Baglin, M Cushman, S Eichinger, ... Journal of thrombosis and haemostasis 10 (6), 1019-1025, 2012 | 527 | 2012 |
| Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C D Williamson, K Brown, R Luddington, C Baglin, T Baglin Blood, The Journal of the American Society of Hematology 91 (4), 1140-1144, 1998 | 445 | 1998 |
| International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer P Debourdeau, D Farge, M Beckers, C Baglin, RM Bauersachs, B Brenner, ... Journal of Thrombosis and Haemostasis 11 (1), 71-80, 2013 | 384 | 2013 |
| Systematic Review: D-Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism M Verhovsek, JD Douketis, Q Yi, S Shrivastava, RC Tait, T Baglin, D Poli, ... Annals of internal medicine 149 (7), 481-490, 2008 | 377 | 2008 |
| Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis J Douketis, A Tosetto, M Marcucci, T Baglin, B Cosmi, M Cushman, ... Bmj 342, 2011 | 369 | 2011 |
| Guidelines on the use and monitoring of heparin. T Baglin, TW Barrowcliffe, A Cohen, M Greaves British journal of haematology 133 (1), 2006 | 356 | 2006 |
| Venous thrombosis AS Wolberg, FR Rosendaal, JI Weitz, IH Jaffer, G Agnelli, T Baglin, ... Nature reviews Disease primers 1 (1), 1-17, 2015 | 347 | 2015 |
| Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee … T Baglin, A Hillarp, A Tripodi, I Elalamy, H Buller, W Ageno Journal of Thrombosis and Haemostasis 11 (4), 756-760, 2013 | 332 | 2013 |
